Trial NCT04965714

View at ClinicalTrials.gov 
Org. Study IDs: 2020-1198
Secondary IDs: 2020-1198 NCI-2021-06214

Last trial update was posted on 2023-02-16

MeSH Interventions

Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Resectable Hepatocellular Carcinoma

Stopping Reasons

0 patient accrual

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID